BD in Holdrege hiring to supply global vaccination effort
BD, a member of Bio Nebraska, plans to add new jobs in Nebraska to support COVID-19 vaccination efforts. Article by the Kearney Hub. Read more
Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs
Sanofi, a member of Bio Nebraska, has entered into an agreement to support the manufacturing and supply of over 125 million does of BioNTech’s COVID-19 vaccine, co-developed by Bio Nebraska member Pfizer. Read more
Phibro Animal Health invests in animal nutrition with renovated facility in Omaha
Phibro Animal Health, a member of Bio Nebraska, announced the opening of its newly renovated plant in Omaha, Nebraska. Story published by National Hog Farmer. Read more
Report Shows Growth of State’s Entrepreneurial Ecosystem under Nebraska Business Innovation Act
The 2020 Economic Impact of Businesses Supported by Nebraska Business Innovation Act Programs report examined outcomes related to one of the state’s main grant opportunities for early-stage businesses, the Nebraska Business Innovation Act. Read more
Nebraska Lawmaker Introduces Legislation to Improve Patient Access to Critical Prescription Medications
LB 337, supported by Bio Nebraska, will reform the insurance industry practice of ‘step therapy’ to give patients and doctors the power to determine the best treatment plan. Read more
Lincoln company aims to develop “second generation” of COVID-19 vaccines
Adjuvance Technologies, a member of Bio Nebraska, aims to be a part of the second generation of COVID-19 vaccines. Reported by Lincoln’s KLKN-TV. Read more
Bio Nebraska Members Included in Collaboration to Evaluate Cancer Early Detection Technology
Bio Nebraska members Grail, Amgen, and Bristol Myers Squibb are included in a collaboration to evaluate cancer early detection technology for minimal residual disease. Read more
FDA Issues Emergency Use Authorization for MatMaCorp’s COVID-19 2SF RNA Test for the Detection of SARS-CoV-2
MatMaCorp a member of Bio Nebraska, announced that the U.S. FDA has granted Emergency Use Authorization of MatMaCorp’s COVID-19 2SF RNA test for the detection of SARS-CoV-2 on the company’s Solas 8® portable detection system. Read more